Key Highlights

• Dr. Ming-Fu Chiang stepped down from the Board of Directors and Scientific Advisory Board of NeOnc Technologies effective June 27, 2026.

• Nasim Shomali has been appointed as a Class II director effective July 1, 2026, serving until the 2027 annual meeting.

• Shomali previously worked at Accenture, providing strategic guidance to Fortune 20 companies during her tenure.

NeOnc Technologies Holdings Inc. Is undergoing a significant leadership transition as Dr. Ming-Fu Chiang resigns from his roles on the Board of Directors and the Scientific Advisory Board. His departure comes during a pivotal time for the company, although no disagreements regarding operations or policies were cited.

Departure of Dr. Chiang

Dr. Chiang's resignation marks a notable shift for NeOnc Technologies. As a director, his leadership contributed to the company's strategic direction. His exit was confirmed, with no further elaboration on the reasons behind his decision, underscoring a focus on seamless organizational continuity.

New Board Member

In response to this change, NeOnc Technologies appointed Nasim Shomali as a director. Shomali's extensive experience will be pivotal for the company as she transitions into her new role. Her tenure is set to last until the next annual stockholder meeting, providing continuity in governance during this transitional period.

Shomali's Background

Nasim Shomali arrives at NeOnc Technologies with a wealth of experience from her time at Accenture, where she worked with leading corporations on strategy and transformation initiatives, positioning her as a valuable asset for the Board.

Strategic Expertise

During her tenure at Accenture, Shomali contributed to essential corporate strategy programs. Her work focused on product redesign, new-product introduction, and market expansion strategies, all of which are likely to inform her decision-making on NeOnc's Board.

Educational Credentials

Shomali has a strong educational foundation that supports her professional role, equipping her to address challenges that NeOnc may face in the healthcare sector.

Family Connection

It is notable that Nasim Shomali is related to a key figure at NeOnc. While connections can often raise questions about governance, the company has clarified that there is no pre-existing arrangement influencing Shomali’s selection as a director.

Conclusion of Transition

With these changes at NeOnc Technologies, both the management team and investors will be watching closely. The new dynamics introduced by Shomali could reshape the strategic directives of the company, offering fresh insights as it navigates its operational landscape in the healthcare sector. NeOnc Technologies operates in a complex and highly regulated environment, where strategic leadership is crucial for success.

The company's ability to adapt to changing market conditions and regulatory requirements will be important factors in its future growth and development.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.